Citation:Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF 2000

Citation

Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2000 Apr 1;47(1):149-55 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10758317.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF 2000	What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?	Associate Professor Shalini Vinod MBBS MD FRANZCR	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?|]] (compare critical appraisals)

Cited by

1. What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?